Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Sep 28, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Sep 11, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record29717 flagged findings
Reported transactions (Form 4)22since May 10, 2023 · and 3 other holdings
Corporate events (8-K)30since Dec 4, 2023
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Listing notice in force
The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of May 26, 2026).
- stockholders' equity · Nasdaq, rule 5550(b)(1) · notice of May 19, 2026 · pending · no automatic period
Reverse splits in 5 years
4 reverse splits in 5 years (1:20 on May 23, 2023, 1:40 on Jan 16, 2024, 1:33 on Dec 4, 2024, 1:28 on May 15, 2025) · 1:739200 cumulative
The other times: of 247 securities that repeated a reverse split in 5 years, a year later the median was worth 0.10× the price on the day of the split; 189 lost more than half and 21 rose (243 with a price a year later).
Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.
The 25 most recent filings (of 297)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Oct 1, 268-K ↗Current report · A debt obligation was accelerated
- Sep 28, 268-K ↗Current report · Other events
- Sep 21, 26Form 3 ↗Insider transaction
- Sep 11, 26Form 4 ↗Insider transaction
- Sep 11, 268-K ↗Current report · A senior executive left or was appointed
- Aug 14, 2610-Q ↗Quarterly report
- Aug 5, 26Form 4 ↗Insider transaction
- Aug 5, 26Form 3 ↗Insider transaction
- Aug 3, 26SCHEDULE 13D/A ↗Stake with intent to influence · DEFJ, LLC · 83.9% · amendment
- Aug 3, 268-K ↗Current report · Change in shareholder rights · Bylaws or fiscal year change
- Jul 28, 26SCHEDULE 13G ↗Passive stake · Unleash Immuno Oncolytics, Inc. · 9.9% · event on Jul 23, 26
- Jul 28, 26SCHEDULE 13G ↗Passive stake · Elena Rosa Braci · 6.2% · event on Jul 23, 26
- Jul 28, 26SCHEDULE 13G ↗Passive stake · Daniel Eduardo Katzman · 5.2% · event on Jul 23, 26
- Jul 27, 26SCHEDULE 13D/A ↗Stake with intent to influence · DEFJ, LLC · 83.9% · amendment
- Jul 23, 26SCHEDULE 13D/A ↗Stake with intent to influence · DEFJ, LLC · 9.9% · amendment
- Jul 20, 26424B3 ↗Securities offering
- Jul 20, 26424B3 ↗Securities offering
- Jul 20, 268-K ↗Current report · Shareholder vote results
- Jul 17, 26SCHEDULE 13D/A ↗Stake with intent to influence · DEFJ, LLC · 8.8% · amendment
- Jul 17, 26DEFA14A ↗Shareholder meeting and votes
- Jul 17, 268-K ↗Current report · Change in shareholder rights · Bylaws or fiscal year change
- Jul 2, 268-K ↗Current report · Other events
- Jun 18, 268-K ↗Current report · Communication to the market
- Jun 3, 268-K ↗Current report · Other events
- Jun 2, 26DEF 14A ↗Shareholder meeting and votes
297 filings on record, the oldest from Jan 15, 21.
Listing the 25 most recent filings of the 297 on record.
15235
- Oct 1, 26A debt obligation was accelerated+1 more in the same filing8-K 2.04 ↗
- Sep 11, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- May 26, 26Listing notice (8-K 3.01)8-K/A 3.01 ↗
- May 22, 26Listing notice (8-K 3.01)8-K 3.01 ↗
- Apr 7, 26Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- Mar 3, 26Sold unregistered shares+5 more in the same filing8-K 3.02 ↗
- Dec 22, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
4 material agreements entered2025show all 4hide
- Oct 17, 25Entered a material agreement+1 more in the same filing8-K/A 1.01 ↗
- Oct 8, 25Entered a material agreement+1 more in the same filing8-K/A 1.01 ↗
- Oct 8, 25Entered a material agreement+7 more in the same filing8-K 1.01 ↗
- Oct 3, 25Entered a material agreement8-K 1.01 ↗
- May 7, 25Listing notice (8-K 3.01)8-K 3.01 ↗
- Mar 25, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Dec 2, 24Entered a material agreement+4 more in the same filing8-K 1.01 ↗
3 listing notices2024show all 3hide
- Nov 6, 24Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Sep 27, 24Listing notice (8-K 3.01)8-K 3.01 ↗
- Aug 16, 24Listing notice (8-K 3.01)8-K 3.01 ↗
5 older filings not shown · The record reaches back to Dec 9, 22.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- May 10, 24Listing notice (8-K 3.01)8-K 3.01 ↗
- Nov 9, 23Listing notice (8-K 3.01)8-K 3.01 ↗
- Oct 27, 23Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
The full record holds 15 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- DEFJ, LLC83.9%Aug 3, 26SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
- CK Life Sciences Int'l., (Holdings) Inc.9.1%Oct 27, 25SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Thomas Joseph Tracy5.0%Mar 7, 25SCHEDULE 13D ↗
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Unleash Immuno Oncolytics, Inc.9.9%Jul 23, 26SCHEDULE 13G ↗
- YA II PN, Ltd.9.9%Apr 15, 26SCHEDULE 13G ↗8 co-filers on this document — the figure is the largest single stake, not their sum.
- Elena Rosa Braci6.2%Jul 23, 26SCHEDULE 13G ↗
- THE GOLDMAN SACHS GROUP, INC.5.9%Jun 30, 25SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- Daniel Eduardo Katzman5.2%Jul 23, 26SCHEDULE 13G ↗
show 2 more holdershide
- SABBY MANAGEMENT, LLC4.9%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Anson Funds Management LP0.1%Jun 30, 25SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- Sep 28, 23Buy$50KRobert Michael DudleyChief Executive Officer↗
- Sep 28, 23Buy$25KThomas A FitzgeraldChief Financial Officer↗
- Jun 21, 23Buy$32KRobert Michael DudleyChief Executive Officer↗
- Jun 20, 23Buy$17KRobert Michael DudleyChief Executive Officer↗
- Jun 9, 23Buy$52KRobert Michael DudleyChief Executive Officer↗
Stock compensation, tax and giftsshow the 2 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
The full record holds 7 transactions and goes back to May 10, 23.
Its sector and its market
Transcode Therapeutics Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Transcode Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Transcode Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 297 documents on file, from Jan 15, 2021 to Oct 1, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.